Despite its promise, the field faces scientific, logistical, and regulatory hurdles. Challenges and future directions in regenerative medicine include issues like limited vascularization, immune rejection, ethical concerns, and scaling up production without compromising quality. As researchers overcome these barriers, future directions point toward integrating AI, robotics, and smart biomaterials for more responsive and adaptive therapies. Standardizing clinical trial design, ensuring equitable access, and aligning global regulations are also key to realizing the full potential of the field. Challenges and future directions in regenerative medicine remain central to the ongoing dialogue among scientists, clinicians, and policymakers striving to make advanced therapies safe, effective, and widely available.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Channel fidelity limits in in-wound hydrogel printing for cartilage regeneration
Evgenia Papadimitriou, AVT.CVT, RWTH University, Germany
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India